Biogipuzkoa Health Research Institute
Clinical trials sponsored by Biogipuzkoa Health Research Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- HIV study aims to uncover hidden health risks in aging patients Results expected Oct 2026 (estimated)
- New combo therapy hopes to slow ALS progression Results expected Nov 2026 (estimated)
- Mediterranean diet tested to ease endometriosis pain Results expected Dec 2026 (estimated)
-
New combo therapy hopes to slow ALS progression
Disease control Recruiting nowThis study tests whether taking N-acetylcysteine (NAC) and EH-301 together with the standard drug riluzole can slow down amyotrophic lateral sclerosis (ALS). About 90 people with early-stage ALS will receive either the active combination or a placebo for 6 months. After that, eve…
Phase 1/2 • Sponsor: Biogipuzkoa Health Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Digital brain training may ease 'chemo brain' — a trial puts it to the test
Symptom relief Recruiting nowThis trial tests whether two types of home-based digital cognitive training can help cancer survivors who have memory, attention, or thinking problems after chemotherapy. Participants will use either a computer program (BrainHQ) or a virtual reality cognitive training for 10 week…
Sponsor: Biogipuzkoa Health Research Institute • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
AI could spot hidden heart risks in menopausal women
Knowledge-focused Recruiting nowThis study aims to develop an artificial intelligence tool that can better predict a woman's risk of heart disease during the menopausal transition. Researchers will collect health data from 3,000 women aged 40 to 60 across Europe and Colombia, including blood tests, blood pressu…
Sponsor: Biogipuzkoa Health Research Institute • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC